Senzar Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Senzar Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-159,256	Closed	-$1.66M	–	35
2017 Q4	$1.66M	Sell	159,256 -36,225	-19%	-$359K	0.42%	29
2017 Q3	$1.39M	Sell	195,481 -15,450	-7%	-$70.6K	0.34%	28
2017 Q2	$1.6M	Sell	210,931 -2,075	-1%	-$15.5K	0.39%	23
2017 Q1	$1.7M	Buy	213,006 +109,900	+107%	+$739K	0.43%	27
2016 Q4	$2.52M	Sell	103,106 -300	-0.3%	-$8.56K	0.67%	26
2016 Q3	$3.92M	Sell	103,406 -7,850	-7%	-$247K	1.01%	26
2016 Q2	$3.31M	Sell	111,256 -75,719	-40%	-$2.66M	0.72%	32
2016 Q1	$5.53M	Buy	186,975 +109,575	+142%	+$3.29M	1.1%	24
2015 Q4	$3.51M	Buy	+77,400	New	+$3.37M	0.39%	38

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Senzar Asset Management's RCKT Position: Q1 2018 in Review

Senzar Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2018, closing a stake of 159,256 shares — an estimated $1.66M sold.

Senzar Asset Management first reported a position in RCKT in Q4 2015 and held it in 9 quarters. The position peaked at $5.53M in Q1 2016. 56 funds tracked by Wall St. Rank hold RCKT as of Q1 2018.

Senzar Asset Management reported no remaining Rocket Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Senzar Asset Management sold 159,256 Rocket Pharmaceuticals shares in Q1 2018, an estimated $1.66M.
Senzar Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2015 and held it in 9 quarters.
Senzar Asset Management's Rocket Pharmaceuticals position peaked at $5.53M in Q1 2016.
56 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2018.

Based on Senzar Asset Management's 13F filing for Q1 2018, filed 14 May 2018.